Last 12 months
Inside the activity.
2 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 2 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 08, 2026 Filed Jul 9, 2026 01:00 UTC |
Loren StefanConsultant
|
GrantStock option (right to buy) · Derivative | 15,000 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001104659-26-082009 · tm2620095-1_4seq1.xml · derivative · entry 1 Loren Stefan · CIK 0001441500 · Consultant 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common stock · 15,000 shares Expires 2036-07-08 F1 · derivative.exercise_date: This option shall vest in full on July 8, 2027, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| July 08, 2026 Filed Jul 10, 2026 21:00 UTC Amendment |
Loren StefanConsultant
|
GrantStock option (right to buy) · Derivative | 15,000 | $0.00 Strike: $2.69 | $0.00 |
DisclosureSEC source: 0001104659-26-082761 · tm2620238-1_4aseq1.xml · derivative · entry 1 Loren Stefan · CIK 0001441500 · Consultant 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common stock · 15,000 shares Expires 2036-07-08 F1 · derivative.exercise_date: This option shall vest in full on July 8, 2027, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| July 07, 2026 Filed Jul 9, 2026 01:10 UTC |
DRISCOLL FREDERICK WDirector
|
GrantStock option (right to buy) · Derivative | 25,000 | $0.00 Strike: $2.70 | $0.00 |
DisclosureSEC source: 0001104659-26-082016 · tm2620095-8_4seq1.xml · derivative · entry 1 DRISCOLL FREDERICK W · CIK 0001129890 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common stock · 25,000 shares Expires 2036-07-07 F1 · derivative.exercise_date: This option shall vest in full on July 7, 2027, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| July 07, 2026 Filed Jul 9, 2026 01:02 UTC |
NEIS JOHNDirector
|
GrantStock option (right to buy) · Derivative | 25,000 | $0.00 Strike: $2.70 | $0.00 |
DisclosureSEC source: 0001104659-26-082010 · tm2620095-2_4seq1.xml · derivative · entry 1 NEIS JOHN · CIK 0001167426 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common stock · 25,000 shares Expires 2036-07-07 F1 · derivative.exercise_date: This option shall vest in full on July 7, 2027, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| July 07, 2026 Filed Jul 9, 2026 01:09 UTC |
Chanan-Khan AsherDirector
|
GrantStock option (right to buy) · Derivative | 25,000 | $0.00 Strike: $2.70 | $0.00 |
DisclosureSEC source: 0001104659-26-082015 · tm2620095-7_4seq1.xml · derivative · entry 1 Chanan-Khan Asher · CIK 0001869837 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common stock · 25,000 shares Expires 2036-07-07 F1 · derivative.exercise_date: This option shall vest in full on July 7, 2027, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| July 07, 2026 Filed Jul 9, 2026 01:13 UTC | GrantStock option (right to buy) · Derivative | 92,000 | $0.00 Strike: $3.14 | $0.00 |
DisclosureSEC source: 0001104659-26-082018 · tm2620095-9_4seq1.xml · derivative · entry 1 Kolean Chad J · CIK 0001616753 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,000 Underlying: Common stock · 92,000 shares Expires 2036-05-28 F1 · date: This option was contingently granted on May 28, 2026, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2026 Annual Meeting of Stockholders. Such stockholder approval was obtained on July 7, 2026. F2 · derivative.exercise_date: This option shall vest over a period of three years from May 28, 2026, with 1/3 vesting on the first anniversary of May 28, 2026, and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of May 28, 2026. Read SEC document |
|
| July 07, 2026 Filed Jul 9, 2026 01:07 UTC |
CARUSO JAMES VDirector · President & CEO
|
GrantStock option (right to buy) · Derivative | 250,000 | $0.00 Strike: $3.14 | $0.00 |
DisclosureSEC source: 0001104659-26-082014 · tm2620095-6_4seq1.xml · derivative · entry 1 CARUSO JAMES V · CIK 0001202770 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Underlying: Common stock · 250,000 shares Expires 2036-05-28 F1 · date: This option was contingently granted on May 28, 2026, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2026 Annual Meeting of Stockholders. Such stockholder approval was obtained on July 7, 2026. F2 · derivative.exercise_date: This option shall vest over a period of three years from May 28, 2026, with 1/3 vesting on the first anniversary of May 28, 2026, and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of May 28, 2026 Read SEC document |
| July 07, 2026 Filed Jul 9, 2026 01:06 UTC |
Gu AndrewDirector
|
GrantStock option (right to buy) · Derivative | 25,000 | $0.00 Strike: $2.70 | $0.00 |
DisclosureSEC source: 0001104659-26-082013 · tm2620095-5_4seq1.xml · derivative · entry 1 Gu Andrew · CIK 0002137966 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common stock · 25,000 shares Expires 2036-07-07 F1 · derivative.exercise_date: This option shall vest in full on July 7, 2027, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| July 07, 2026 Filed Jul 9, 2026 01:04 UTC |
Swirsky Douglas JDirector
|
GrantStock option (right to buy) · Derivative | 37,500 | $0.00 Strike: $2.70 | $0.00 |
DisclosureSEC source: 0001104659-26-082011 · tm2620095-3_4seq1.xml · derivative · entry 1 Swirsky Douglas J · CIK 0001375884 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,500 Underlying: Common stock · 37,500 shares Expires 2036-07-07 F1 · derivative.exercise_date: This option shall vest in full on July 7, 2027, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| July 07, 2026 Filed Jul 9, 2026 01:05 UTC |
Longcor JarrodChief Operating Officer
|
GrantStock option (right to buy) · Derivative | 118,000 | $0.00 Strike: $3.14 | $0.00 |
DisclosureSEC source: 0001104659-26-082012 · tm2620095-4_4seq1.xml · derivative · entry 1 Longcor Jarrod · CIK 0001545565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,000 Underlying: Common stock · 118,000 shares Expires 2036-05-28 F1 · date: This option was contingently granted on May 28, 2026, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2026 Annual Meeting of Stockholders. Such stockholder approval was obtained on July 7, 2026. F2 · derivative.exercise_date: This option shall vest over a period of three years from May 28, 2026, with 1/3 vesting on the first anniversary of May 28, 2026, and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of May 28, 2026 Read SEC document |
| May 07, 2026 Filed May 12, 2026 00:07 UTC |
Longcor JarrodChief Operating Officer
|
PurchaseWarrants · Derivative | 26,040 | $0.01 Strike: $2.88 | $260.40 |
DisclosureSEC source: 0001104659-26-058854 · tm2614289-2_4seq1.xml · derivative · entry 2 Longcor Jarrod · CIK 0001545565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,149 Underlying: Common Stock · 26,040 shares Expires not disclosed F1 · derivative.expiration_date: Expiration dates are as follows: Tranche A shall have a one-year term from the date of stockholder approval; Tranche B shall have a two-year term from the date of stockholder approval; Tranche C shall have a five-year term from the date of stockholder approval. Read SEC document |
| May 07, 2026 Filed May 12, 2026 00:07 UTC |
Longcor JarrodChief Operating Officer
|
PurchaseCommon Stock | 8,680 | $2.88 | $24,998.40 |
DisclosureSEC source: 0001104659-26-058854 · tm2614289-2_4seq1.xml · nonDerivative · entry 1 Longcor Jarrod · CIK 0001545565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,451 Read SEC document |
| May 07, 2026 Filed May 12, 2026 00:05 UTC |
CARUSO JAMES VDirector · Chief Executive Officer
|
PurchaseWarrants · Derivative | 26,040 | $0.01 Strike: $2.88 | $260.40 |
DisclosureSEC source: 0001104659-26-058851 · tm2614289-1_4seq1.xml · derivative · entry 2 CARUSO JAMES V · CIK 0001202770 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,076 Underlying: Common Stock · 26,040 shares Expires not disclosed F1 · derivative.expiration_date: Expiration dates are as follows: Tranche A shall have a one-year term from the date of stockholder approval; Tranche B shall have a two-year term from the date of stockholder approval; Tranche C shall have a five-year term from the date of stockholder approval. Read SEC document |
| May 07, 2026 Filed May 12, 2026 00:05 UTC |
CARUSO JAMES VDirector · Chief Executive Officer
|
PurchaseCommon Stock | 8,680 | $2.88 | $24,998.40 |
DisclosureSEC source: 0001104659-26-058851 · tm2614289-1_4seq1.xml · nonDerivative · entry 1 CARUSO JAMES V · CIK 0001202770 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,318 Read SEC document |
| December 12, 2025 Filed Dec 16, 2025 23:00 UTC |
NEIS JOHNDirector
|
SaleCommon Stock | 198 | $3.70 | $731.99 |
DisclosureSEC source: 0001104659-25-121691 · tm2533642-1_4seq1.xml · nonDerivative · entry 1 NEIS JOHN · CIK 0001167426 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 10 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.631 to $3.70, inclusive. The reporting person has provided to the Issuer, and undertakes to provide to any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote (1) to this Form 4. F2 · balance_after: This number has been adjusted for (i) the one-for-thirty (1:30) reverse stock split effected by the Issuer on June 24, 2025, (ii) the one-for-ten (1:10) reverse stock split effected by the Issuer on July 21, 2022, and (iii) the one-for-ten (1:10) reverse stock split effected by the Issuer on July 16, 2018. F3 · ownership.nature: These securities are held by Advantage Capital Wisconsin Partners I, Limited Partnership. Venture Investors LLC is the submanager and special limited partner of Advantage Capital Wisconsin Partners I, Limited Partnership. The investment decisions of Venture Investors LLC are made collectively by five managers, including the reporting person. The reporting person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest herein. Read SEC document |
| July 02, 2025 Filed Jul 3, 2025 12:02 UTC |
CARUSO JAMES VDirector · Chief Executive Officer
|
PurchaseWarrants · Derivative | 10,000 | $0.01 Strike: $5.25 | $100.00 |
DisclosureSEC source: 0001104659-25-065573 · tm2519819-3_4seq1.xml · derivative · entry 2 CARUSO JAMES V · CIK 0001202770 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-07-02 Read SEC document |
| July 02, 2025 Filed Jul 3, 2025 12:02 UTC |
CARUSO JAMES VDirector · Chief Executive Officer
|
PurchaseCommon Stock | 10,000 | $4.99 | $49,900.00 |
DisclosureSEC source: 0001104659-25-065573 · tm2519819-3_4seq1.xml · nonDerivative · entry 1 CARUSO JAMES V · CIK 0001202770 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,638 F1 · balance_after: This number has been adjusted for the one-for-thirty (1:30) reverse stock split effected by the Issuer on June 24, 2025. Read SEC document |
| July 02, 2025 Filed Jul 3, 2025 12:01 UTC |
Longcor JarrodChief Operating Officer
|
PurchaseWarrants · Derivative | 10,000 | $0.01 Strike: $5.25 | $100.00 |
DisclosureSEC source: 0001104659-25-065572 · tm2519819-2_4seq1.xml · derivative · entry 2 Longcor Jarrod · CIK 0001545565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-07-02 Read SEC document |
| July 02, 2025 Filed Jul 3, 2025 12:01 UTC |
Longcor JarrodChief Operating Officer
|
PurchaseCommon Stock | 10,000 | $4.99 | $49,900.00 |
DisclosureSEC source: 0001104659-25-065572 · tm2519819-2_4seq1.xml · nonDerivative · entry 1 Longcor Jarrod · CIK 0001545565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,768 F1 · balance_after: This number has been adjusted for the one-for-thirty (1:30) reverse stock split effected by the Issuer on June 24, 2025. Read SEC document |
| July 02, 2025 Filed Jul 3, 2025 12:00 UTC |
Kolean Chad JChief Financial Officer
|
PurchaseWarrants · Derivative | 5,000 | $0.01 Strike: $5.25 | $50.00 |
DisclosureSEC source: 0001104659-25-065570 · tm2519819-1_4seq1.xml · derivative · entry 2 Kolean Chad J · CIK 0001616753 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2030-07-02 Read SEC document |
| July 02, 2025 Filed Jul 3, 2025 12:00 UTC |
Kolean Chad JChief Financial Officer
|
PurchaseCommon Stock | 5,000 | $4.99 | $24,950.00 |
DisclosureSEC source: 0001104659-25-065570 · tm2519819-1_4seq1.xml · nonDerivative · entry 1 Kolean Chad J · CIK 0001616753 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,418 F1 · balance_after: This number has been adjusted for the one-for-thirty (1:30) reverse stock split effected by the Issuer on June 24, 2025. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 21:03 UTC |
DRISCOLL FREDERICK WDirector
|
GrantStock option (right to buy) · Derivative | 60,000 | $0.00 Strike: $0.29 | $0.00 |
DisclosureSEC source: 0001104659-25-014740 · tm256830-3_4seq1.xml · derivative · entry 1 DRISCOLL FREDERICK W · CIK 0001129890 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2035-02-14 F1 · derivative.exercise_date: This option shall vest in full on February 14, 2026, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 21:06 UTC |
NEIS JOHNDirector
|
GrantStock option (right to buy) · Derivative | 60,000 | $0.00 Strike: $0.29 | $0.00 |
DisclosureSEC source: 0001104659-25-014753 · tm256830d7_4seq1.xml · derivative · entry 1 NEIS JOHN · CIK 0001167426 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2035-02-14 F1 · derivative.exercise_date: This option shall vest in full on February 14, 2026, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 21:02 UTC |
Chanan-Khan AsherDirector
|
GrantStock option (right to buy) · Derivative | 60,000 | $0.00 Strike: $0.29 | $0.00 |
DisclosureSEC source: 0001104659-25-014737 · tm256830-2_4seq1.xml · derivative · entry 1 Chanan-Khan Asher · CIK 0001869837 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2035-02-14 F1 · derivative.exercise_date: This option shall vest in full on February 14, 2026, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 21:05 UTC |
Loren StefanDirector
|
GrantStock option (right to buy) · Derivative | 60,000 | $0.00 Strike: $0.29 | $0.00 |
DisclosureSEC source: 0001104659-25-014752 · tm256830-6_4seq1.xml · derivative · entry 1 Loren Stefan · CIK 0001441500 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2035-02-14 F1 · derivative.exercise_date: This option shall vest in full on February 14, 2026, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 21:07 UTC |
Swirsky Douglas JDirector
|
GrantStock option (right to buy) · Derivative | 90,000 | $0.00 Strike: $0.29 | $0.00 |
DisclosureSEC source: 0001104659-25-014757 · tm256830-8_4seq1.xml · derivative · entry 1 Swirsky Douglas J · CIK 0001375884 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2035-02-14 F1 · derivative.exercise_date: This option shall vest in full on February 14, 2026, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 21:04 UTC |
Kolean Chad JChief Financial Officer
|
GrantStock option (right to buy) · Derivative | 290,000 | $0.00 Strike: $0.29 | $0.00 |
DisclosureSEC source: 0001104659-25-014742 · tm256830-4_4seq1.xml · derivative · entry 1 Kolean Chad J · CIK 0001616753 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 290,000 Underlying: Common Stock · 290,000 shares Expires 2035-02-14 F1 · derivative.exercise_date: This option shall vest over a period of three years from February 14, 2025, with 1/3 vesting on the first anniversary of February 14, 2026 and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of February 14, 2026. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 21:05 UTC |
Longcor JarrodChief Operating Officer
|
GrantStock option (right to buy) · Derivative | 500,000 | $0.00 Strike: $0.29 | $0.00 |
DisclosureSEC source: 0001104659-25-014744 · tm256830-5_4seq1.xml · derivative · entry 1 Longcor Jarrod · CIK 0001545565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2035-02-14 F1 · derivative.exercise_date: This option shall vest over a period of three years from February 14, 2025, with 1/3 vesting on the first anniversary of February 14, 2026 and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of February 14, 2026. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 21:01 UTC |
CARUSO JAMES VDirector · President and CEO
|
GrantStock option (right to buy) · Derivative | 900,000 | $0.00 Strike: $0.29 | $0.00 |
DisclosureSEC source: 0001104659-25-014730 · tm256830-1_4seq1.xml · derivative · entry 1 CARUSO JAMES V · CIK 0001202770 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 900,000 Underlying: Common Stock · 900,000 shares Expires 2035-02-14 F1 · derivative.exercise_date: This option shall vest over a period of three years from February 14, 2025, with 1/3 vesting on the first anniversary of February 14, 2026 and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of February 14, 2026. Read SEC document |
| January 10, 2025 Filed Mar 13, 2025 01:44 UTC |
Longcor JarrodChief Operating Officer
|
PurchaseCommon Stock | 30,000 | $0.28 | $8,400.00 |
DisclosureSEC source: 0001104659-25-023121 · tm259066-1_4seq1.xml · nonDerivative · entry 1 Longcor Jarrod · CIK 0001545565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,141 Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 21:00 UTC |
DRISCOLL FREDERICK WDirector
|
GrantStock option (right to buy) · Derivative | 60,000 | $0.00 Strike: $2.58 | $0.00 |
DisclosureSEC source: 0001104659-24-072880 · tm2417520-2_4seq1.xml · derivative · entry 1 DRISCOLL FREDERICK W · CIK 0001129890 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2033-12-22 F1 · date: This option was contingently granted on December 22, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2024 Annual Meeting of Stockholders. Such stockholder approval was obtained on June 14, 2024. F2 · derivative.exercise_date: This option shall vest in full on December 22, 2024, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 21:00 UTC |
NEIS JOHNDirector
|
GrantStock option (right to buy) · Derivative | 60,000 | $0.00 Strike: $2.58 | $0.00 |
DisclosureSEC source: 0001104659-24-072881 · tm2417520-3_4seq1.xml · derivative · entry 1 NEIS JOHN · CIK 0001167426 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2033-12-22 F1 · date: This option was contingently granted on December 22, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2024 Annual Meeting of Stockholders. Such stockholder approval was obtained on June 14, 2024. F2 · derivative.exercise_date: This option shall vest in full on December 22, 2024, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 21:00 UTC |
Chanan-Khan AsherDirector
|
GrantStock option (right to buy) · Derivative | 60,000 | $0.00 Strike: $2.58 | $0.00 |
DisclosureSEC source: 0001104659-24-072875 · tm2417520-1_4seq1.xml · derivative · entry 1 Chanan-Khan Asher · CIK 0001869837 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2033-12-22 F1 · date: This option was contingently granted on December 22, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2024 Annual Meeting of Stockholders. Such stockholder approval was obtained on June 14, 2024. F2 · derivative.exercise_date: This option shall vest in full on December 22, 2024, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 21:01 UTC |
Loren StefanDirector
|
GrantStock option (right to buy) · Derivative | 60,000 | $0.00 Strike: $2.58 | $0.00 |
DisclosureSEC source: 0001104659-24-072883 · tm2417520-5_4seq1.xml · derivative · entry 1 Loren Stefan · CIK 0001441500 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2033-12-22 F1 · date: This option was contingently granted on December 22, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2024 Annual Meeting of Stockholders. Such stockholder approval was obtained on June 14, 2024. F2 · derivative.exercise_date: This option shall vest in full on December 22, 2024, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 21:04 UTC |
Longcor JarrodChief Operating Officer
|
GrantStock option (right to buy) · Derivative | 500,000 | $0.00 Strike: $2.65 | $0.00 |
DisclosureSEC source: 0001104659-24-072891 · tm2417520-10_4seq1.xml · derivative · entry 1 Longcor Jarrod · CIK 0001545565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2033-12-15 F1 · date: This option was contingently granted on December 15, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2024 Annual Meeting of Stockholders. Such stockholder approval was obtained on June 14, 2024. F2 · derivative.exercise_date: This option shall vest over a period of three years from December 15, 2023, with 1/3 vesting on the first anniversary of Decembner 15, 2023 and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of Decembner 15, 2023. Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 21:03 UTC |
Shustov AndreiSenior Vice President, Medical
|
GrantStock option (right to buy) · Derivative | 260,000 | $0.00 Strike: $2.65 | $0.00 |
DisclosureSEC source: 0001104659-24-072886 · tm2417520-7_4seq1.xml · derivative · entry 1 Shustov Andrei · CIK 0001969686 · Senior Vice President, Medical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 260,000 Underlying: Common Stock · 260,000 shares Expires 2033-12-15 F1 · date: This option was contingently granted on December 15, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2024 Annual Meeting of Stockholders. Such stockholder approval was obtained on June 14, 2024. F2 · derivative.exercise_date: This option shall vest over a period of three years from December 15, 2023, with 1/3 vesting on the first anniversary of Decembner 15, 2023 and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of Decembner 15, 2023. Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 21:04 UTC |
CARUSO JAMES VDirector · President and CEO
|
GrantStock option (right to buy) · Derivative | 900,000 | $0.00 Strike: $2.65 | $0.00 |
DisclosureSEC source: 0001104659-24-072889 · tm2417520-9_4seq1.xml · derivative · entry 1 CARUSO JAMES V · CIK 0001202770 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 900,000 Underlying: Common Stock · 900,000 shares Expires 2033-12-15 F1 · date: This option was contingently granted on December 15, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2024 Annual Meeting of Stockholders. Such stockholder approval was obtained on June 14, 2024. F2 · derivative.exercise_date: This option shall vest over a period of three years from December 15, 2023, with 1/3 vesting on the first anniversary of Decembner 15, 2023 and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of Decembner 15, 2023. Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 21:04 UTC |
Kolean Chad JChief Financial Officer
|
GrantStock option (right to buy) · Derivative | 290,000 | $0.00 Strike: $2.65 | $0.00 |
DisclosureSEC source: 0001104659-24-072887 · tm2417520-8_4seq1.xml · derivative · entry 1 Kolean Chad J · CIK 0001616753 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 290,000 Underlying: Common Stock · 290,000 shares Expires 2033-12-15 F1 · date: This option was contingently granted on December 15, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2024 Annual Meeting of Stockholders. Such stockholder approval was obtained on June 14, 2024. F2 · derivative.exercise_date: This option shall vest over a period of three years from December 15, 2023, with 1/3 vesting on the first anniversary of Decembner 15, 2023 and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of Decembner 15, 2023. Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 21:02 UTC |
Lea Darrell ShaneChief Commercial Officer
|
GrantStock option (right to buy) · Derivative | 260,000 | $0.00 Strike: $2.65 | $0.00 |
DisclosureSEC source: 0001104659-24-072885 · tm2417520-6_4seq1.xml · derivative · entry 1 Lea Darrell Shane · CIK 0001958526 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 260,000 Underlying: Common Stock · 260,000 shares Expires 2033-12-15 F1 · date: This option was contingently granted on December 15, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2024 Annual Meeting of Stockholders. Such stockholder approval was obtained on June 14, 2024. F2 · derivative.exercise_date: This option shall vest over a period of three years from December 15, 2023, with 1/3 vesting on the first anniversary of Decembner 15, 2023 and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of Decembner 15, 2023. Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 21:01 UTC |
Swirsky Douglas JDirector
|
GrantStock option (right to buy) · Derivative | 90,000 | $0.00 Strike: $2.58 | $0.00 |
DisclosureSEC source: 0001104659-24-072882 · tm2417520-4_4seq1.xml · derivative · entry 1 Swirsky Douglas J · CIK 0001375884 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2033-12-22 F1 · date: This option was contingently granted on December 22, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2024 Annual Meeting of Stockholders. Such stockholder approval was obtained on June 14, 2024. F2 · derivative.exercise_date: This option shall vest in full on December 22, 2024, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| December 08, 2023 Filed Dec 13, 2023 01:09 UTC |
Lea Darrell ShaneChief Commercial Officer
|
GrantCommon Stock | 39,599 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-125488 · tm2332764-3_4seq1.xml · nonDerivative · entry 1 Lea Darrell Shane · CIK 0001958526 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,599 Read SEC document |
| December 08, 2023 Filed Dec 13, 2023 01:07 UTC |
Kolean Chad JChief Financial Officer
|
GrantCommon Stock | 42,554 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-125486 · tm2332764-2_4seq1.xml · nonDerivative · entry 1 Kolean Chad J · CIK 0001616753 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,578 Read SEC document |
| December 08, 2023 Filed Dec 13, 2023 01:04 UTC |
Longcor JarrodChief Operating Officer
|
GrantCommon Stock | 42,927 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-125484 · tm2332764-4_4seq1.xml · nonDerivative · entry 1 Longcor Jarrod · CIK 0001545565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,141 Read SEC document |
| December 08, 2023 Filed Dec 13, 2023 01:05 UTC |
Shustov AndreiSenior Vice President, Medical
|
GrantCommon Stock | 47,856 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-125485 · tm2332764-5_4seq1.xml · nonDerivative · entry 1 Shustov Andrei · CIK 0001969686 · Senior Vice President, Medical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,037.7 Read SEC document |
| December 08, 2023 Filed Dec 13, 2023 01:04 UTC |
CARUSO JAMES VDirector · President and CEO
|
GrantCommon Stock | 40,596 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-125483 · tm2332764-1_4seq1.xml · nonDerivative · entry 1 CARUSO JAMES V · CIK 0001202770 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,236 Read SEC document |
| June 28, 2023 Filed Jun 28, 2023 22:24 UTC |
DRISCOLL FREDERICK WDirector
|
GrantStock option (right to buy) · Derivative | 25,000 | $0.00 Strike: $1.85 | $0.00 |
DisclosureSEC source: 0001104659-23-075938 · tm2320030-2_4seq1.xml · derivative · entry 1 DRISCOLL FREDERICK W · CIK 0001129890 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,650 Underlying: Common Stock · 25,000 shares Expires 2033-06-28 F1 · derivative.exercise_date: This stock option shall vest in full on June 28, 2024, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| June 28, 2023 Filed Jun 28, 2023 22:26 UTC |
NEIS JOHNDirector
|
GrantStock option (right to buy) · Derivative | 25,000 | $0.00 Strike: $1.85 | $0.00 |
DisclosureSEC source: 0001104659-23-075940 · tm2320030-4_4seq1.xml · derivative · entry 1 NEIS JOHN · CIK 0001167426 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,887 Underlying: Common Stock · 25,000 shares Expires 2033-06-28 F1 · derivative.exercise_date: This stock option shall vest in full on June 28, 2024, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| June 28, 2023 Filed Jun 28, 2023 22:24 UTC |
Chanan-Khan AsherDirector
|
GrantStock option (right to buy) · Derivative | 25,000 | $0.00 Strike: $1.85 | $0.00 |
DisclosureSEC source: 0001104659-23-075937 · tm2320030-1_4seq1.xml · derivative · entry 1 Chanan-Khan Asher · CIK 0001869837 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,600 Underlying: Common Stock · 25,000 shares Expires 2033-06-28 F1 · derivative.exercise_date: This stock option shall vest in full on June 28, 2024, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| June 28, 2023 Filed Jun 28, 2023 22:25 UTC |
Loren StefanDirector
|
GrantStock option (right to buy) · Derivative | 25,000 | $0.00 Strike: $1.85 | $0.00 |
DisclosureSEC source: 0001104659-23-075939 · tm2320030-3_4seq1.xml · derivative · entry 1 Loren Stefan · CIK 0001441500 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,885 Underlying: Common Stock · 25,000 shares Expires 2033-06-28 F1 · derivative.exercise_date: This stock option shall vest in full on June 28, 2024, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| June 28, 2023 Filed Jun 28, 2023 22:27 UTC |
Swirsky Douglas JDirector
|
GrantStock option (right to buy) · Derivative | 37,500 | $0.00 Strike: $1.85 | $0.00 |
DisclosureSEC source: 0001104659-23-075942 · tm2320030-5_4seq1.xml · derivative · entry 1 Swirsky Douglas J · CIK 0001375884 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,925 Underlying: Common Stock · 37,500 shares Expires 2033-06-28 F1 · derivative.exercise_date: This stock option shall vest in full on June 28, 2024, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.